RESUMO
By adapting a citrate phosphate dextrose (CPD) whole blood storage bag, residual blood from a renal replacement therapy (RRT) circuit can be saved in pediatric patients, decreasing in donor exposure later. The techniques used for autologous preoperative blood storage are the basis of storing the RRT circuit blood. The CPD anticoagulant has a benefit of having a commonly used reversal agent for its anticoagulant properties, i.e., calcium. Also, unlike the traditional anticoagulants used in extracorporeal membrane oxygenation (ECMO), i.e., heparin, and direct thrombin inhibitors, i.e., bivalirudin, there is no increase in anticoagulation laboratory parameters after administration. The CPD volume in the bag is reduced but keeps the original ratio the same between CPD and blood. This is accomplished by removing all CPD from the bag, adding back only the exact amount of CPD needed for the smaller amount of blood being transferred from the circuit. The RRT circuit managed at our institution uses 23 mL of CPD for 165 mL of circuit blood when stored with this technique. This calculation assumes a normal patient calcium level. This technique has been used successfully multiple times in more than 30 pediatric patients without incident for 7 years at our center. The CPD bag can also be used to store the residual blood from ECMO circuits after removal of ECMO to allow the blood to be given back to the patient at a later time by keeping the same citrate-to-blood ratio.
Assuntos
Oxigenação por Membrana Extracorpórea , Anticoagulantes , Criança , Citratos , Glucose , Humanos , Terapia de Substituição RenalRESUMO
Extracorporeal membrane oxygenation (ECMO) is used to treat severe hypoxemic respiratory failure and as a rescue therapy for patients with cardiopulmonary arrest within a narrow window of time. A failure modes and effects analysis (FMEA) was conducted to analyze the clinical and operational processes leading to delays in initiating ECMO. FMEA determined these highest-risk failure modes that were contributing to process failure: (1) ECMO candidacy not determined in time, (2) no or incomplete evaluation for ECMO prior to consult or arrest, (3) ECMO team not immediately available, and (4) cannulation not completed in time. When implemented collectively, a total of 4 interventions addressed more than 95% of the system failures. These interventions were (1) ECMO response pager held by a team required for decision, (2) distribution of institutionally defined inclusion/exclusion criteria, (3) educational training for clinicians consulting the ECMO team, and (4) establishment of a mobile ECMO insertion cart.
Assuntos
Oxigenação por Membrana Extracorpórea , Análise do Modo e do Efeito de Falhas na Assistência à Saúde/organização & administração , Humanos , Cuidados para Prolongar a Vida , Minnesota , Insuficiência Respiratória/terapia , Estudos Retrospectivos , Centros de Atenção TerciáriaRESUMO
This column discusses the use of thromboelastographic studies when assessing patients with bleeding disorders.
Assuntos
Transtornos da Coagulação Sanguínea/diagnóstico , Avaliação em Enfermagem/métodos , Tromboelastografia/métodos , Algoritmos , Transtornos da Coagulação Sanguínea/sangue , Transtornos da Coagulação Sanguínea/complicações , Hemorragia/etiologia , Humanos , Seleção de Pacientes , Sistemas Automatizados de Assistência Junto ao Leito , Valores de Referência , Reprodutibilidade dos Testes , Tromboelastografia/enfermagem , Tromboelastografia/normasRESUMO
This column discusses the factors affecting hemostasis and the common coagulation studies used to assess patients with bleeding disorders.